Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
ANI Pharmaceuticals, Inc.
*STREET
210 Main Street West
*CITY
Baudette
*STATE
(Required for U.S. applicants)
Minnesota
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
56623
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Medicinal hormone preparation
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Samuel Fifer
ATTORNEY DOCKET NUMBER
20000516.030
FIRM NAME
Dentons US LLP
INTERNAL ADDRESS
Wacker Drive Station, Willis Tower
STREET
P.O. Box #061080
CITY
Chicago
STATE
Illinois
COUNTRY
United States
ZIP/POSTAL CODE
60606
PHONE
312-876-3114
FAX
312-876-7934
EMAIL ADDRESS
trademarks.us@dentons.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Paul A. Gajer, Carol Anne Been, Tara Reedy Sliva, David R. Metzger, Monica B. Richman, Joel N. Bock, Belinda B. May, Brian R. McGinley, Mary
S. Mathew, Tiffany L. Schwartz, Kate E. Hart, Francesca Montalvo Witzburg, and Callie L. Pioli
CORRESPONDENCE INFORMATION
NAME
Samuel Fifer
FIRM NAME
Dentons US LLP
INTERNAL ADDRESS
Wacker Drive Station, Willis Tower
STREET
P.O. Box #061080
CITY
Chicago
STATE
Illinois
COUNTRY
United States
ZIP/POSTAL CODE
60606
PHONE
312-876-3114
FAX
312-876-7934
*EMAIL ADDRESS
trademarks.us@dentons.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/Samuel Fifer/
SIGNATORY'S NAME
Samuel Fifer
SIGNATORY'S POSITION
Attorney of record, Illinois bar member
SIGNATORY'S PHONE NUMBER
312-876-3114
DATE SIGNED
01/16/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88263617
Filing Date:01/16/2019
To the Commissioner for Trademarks:
MARK: CORTROPHIN (Standard Characters, see mark)
The literal element of the mark consists of CORTROPHIN.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, ANI Pharmaceuticals, Inc., a corporation of Delaware, having an address of
210 Main Street West
Baudette, Minnesota 56623
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Medicinal hormone preparation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Samuel Fifer and Paul A. Gajer, Carol Anne Been, Tara Reedy Sliva, David R. Metzger, Monica B. Richman, Joel N. Bock, Belinda B. May, Brian R. McGinley, Mary S.
Mathew, Tiffany L. Schwartz, Kate E. Hart, Francesca Montalvo Witzburg, and Callie L. Pioli of Dentons US LLP
Wacker Drive Station, Willis Tower
P.O. Box #061080
Chicago, Illinois 60606
United States
312-876-3114(phone)
312-876-7934(fax)
trademarks.us@dentons.com (authorized)
The attorney docket/reference number is 20000516.030.
The applicant's current Correspondence Information:
trademarks.us@dentons.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Samuel Fifer/ Date: 01/16/2019
Signatory's Name: Samuel Fifer
Signatory's Position: Attorney of record, Illinois bar member
Payment Sale Number: 88263617
Payment Accounting Date: 01/16/2019
Serial Number: 88263617
Internet Transmission Date: Wed Jan 16 11:22:16 EST 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201901161122167
47754-88263617-62043e9ce246a2041715b1626
5694e6ed4b8f755c5517a9412155665483889712
-CC-11897-20190115112744458267